STAAR Surgical Co (STAA) Narxning foydaga nisbati

STAAR Surgical Corp - STAA emitenti grafik logotipi

STAAR Surgical Company (STAA) ekotizimi innovatsion linzalar va shifokorlar treningi o'rtasidagi sinergiyaga tayanadi, bu esa GURU.Markets tizimi tomonidan taqdim etilgan emitentning P/E ko'rsatkichi bilan qo'llab-quvvatlanadi, shu bilan birga 2456.00 belgisi ushbu metrikaning joriy holatini ko'rsatadi. STAAR Surgical Company (STAA) lazerli ko'rishni tuzatishga muqobil sifatida premium Collamer mahsulotini yaratadi, garchi makroiqtisodiy bosim va Osiyodagi tartibga soluvchi to'siqlar o'sish sur'atlari uchun ma'lum risklarni yuzaga keltirsa-da.

STAAR Surgical (STAA) - P/E multiplikatori 04.07.2022dan 15.11.2026gacha

STAAR Surgical Company kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:STAAR Surgical Co., STAA
STAAR Surgical Company tovar namunasi

P/E koeffitsiyenti foydaning bir birligi uchun xarajatni belgilaydi, bu esa investorga inflyatsiya kutilmalari va Fed stavkalari asosida aktiv uchun haddan tashqari to'lov darajasini baholash imkonini beradi. STAAR Surgical Company (STAA) kompaniyasining 12 oylik orqa sirpanuvchi (TTM) P/E koeffitsiyenti tahlil qilinganda, ushbu multiplikatorning barqarorligi oftalmik implantlarga bo'lgan turg'un talab bilan ta'minlanishi ta'kidlanishi lozim, bunda ushbu talab geosiyosiy sanksiyalarga e'tibor bermaydi va Osiyo bozorlarida muvaffaqiyatli sertifikatsiyadan o'tmoqda.

Raqobatdosh kompaniyalar tahlili

P/E multiplikatori Intuitive Surgical, Inc.|Narx-foyda koeffitsiyenti DHR (Danaher Corp)|BDX (Becton, Dickinson and Company) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori STE (steris.com)|Biznesning o‘zini qoplash muddati westpharma.com (WST)|BAX - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Masimo Corp MASI|Stevanato Group S.p.A. (STVN) - Narxning foydaga nisbati|TFX - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati merit.com|Envista (NVST) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti ICUI (ICU Medical, Inc.)|Bozor narxining sof foydaga nisbati XRAY|Narxning foydaga nisbati LeMaitre LMAT|Kompaniya qiymatining sof foydaga nisbati ATRC|NAGE: Narx-foyda koeffitsiyenti|ZIMV - P/E multiplikatori|AngioDynamics Inc (ANGO) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Cerus|TKNO (teknova.com) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Monogram Orthopedics Inc. MGRM|Narxning foydaga nisbati Sharps Tech (STSS)|InfuSystem Inc - Narx-foyda multiplikatori|Utah Medical Products - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati KRMD (KORU Medical Systems)|NYXH - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Microbot Medical, Inc MBOT|Pro-Dex Corp (PDEX) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati ZTEK (Zentek Ltd.)|Narxning foydaga nisbati Elutia|Milestone Scientific Inc (MLSS) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti NXGL (NEXGEL, Inc.)|RVP (Retractable Technologies, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Harvard Bioscience, Inc. - Narx-foyda koeffitsiyenti|P/E multiplikatori femasys.com FEMY|MHUA: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati predictive-oncology.com POAI|Callan JMB Inc (CJMB) - Narxning foydaga nisbati|Narx-foyda multiplikatori ATRI|NURO (NeuroMetrix Inc) - P/E multiplikatori